Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2007
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
03/21/2007EP1385492B1 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
03/21/2007EP1365787B1 Use of amino acid anticonvulsants for treatment of pain
03/21/2007EP1337261B1 Laminarin sulphate-based anti-inflammatory medicament
03/21/2007EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines
03/21/2007EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases
03/21/2007EP1216024B1 Formulation for menopausal women
03/21/2007EP1207872B1 Ibuprofen-containing softgels
03/21/2007EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use
03/21/2007EP1049717B1 Antibodies against human il-12
03/21/2007CN2880080Y Far infrared heating type mediated plaster
03/21/2007CN1934256A Decoy nucleic acid to synoviolin gene promoter
03/21/2007CN1934252A Thrombin derivatives and medicinal composition containing the same
03/21/2007CN1934113A Compositions useful as inhibitors of protein kinases
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
03/21/2007CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors
03/21/2007CN1933814A S/O type pharmaceutical preparation and process for producing the same
03/21/2007CN1931875A High purity ulinastatin and its prepn process and medicine composition
03/21/2007CN1931859A New fused imidazole derivative
03/21/2007CN1931359A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931358A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931355A Arthritis treating and swelling eliminating medicine powder
03/21/2007CN1931328A Multifunctional paster
03/21/2007CN1931325A Health medicinal wine with functions of invigorating kidney and resisting rheumatism and its prepn process
03/21/2007CN1931320A Medicinal wine composition and its prepn process
03/21/2007CN1931313A Chinese herbal medicine digestant for treating lymphoid tuberculosis and cervical lymphadenitis
03/21/2007CN1931305A Aerosol for treating rheumatism and its prepn process
03/21/2007CN1931300A Externally applied medicine for treating women's dysmenorrhea
03/21/2007CN1931298A Medicine for treating wind-damp arthralgia and hyperosteogeny
03/21/2007CN1931295A Wind dispelling spray and its prepn process
03/21/2007CN1931290A Making process of plaster for treating pain in neck, shoulders, waist and legs
03/21/2007CN1931288A Medicinal wine for eliminating swelling sore
03/21/2007CN1931286A Chinese medicine composition for treating lung cancer caused pain
03/21/2007CN1931277A Osteoarthrosis treating Chinese medicine composition and its prepn process
03/21/2007CN1931275A Recuperating wine for treating pain in waist and legs
03/21/2007CN1931271A Evodia extract and its prepn process, medicine composition and use
03/21/2007CN1931267A Chinese medicine composition with functions of promoting blood circulation to disperse blood clots and activating qi to stop pain and its prepn process
03/21/2007CN1931262A Common cold treating Chinese medicine prepn
03/21/2007CN1931257A Medicinal wine for treating furuncle
03/21/2007CN1931252A Prepn process of superfine Chinese medicine powder prepn for treating rheumatic disease
03/21/2007CN1931251A Analgesic medicine composition and its prepn process and application
03/21/2007CN1931228A Lysimachia herb total flavone extract and its prepn process
03/21/2007CN1931221A Medicinal wine for treating traumatic injury
03/21/2007CN1931215A Tumor eliminating medicinal wine
03/21/2007CN1931213A Tuniclike psammosilene root extract and its prep. medicine composition and use
03/21/2007CN1931204A Nasal in-situ gel prepn containing volatile bupleurum oil
03/21/2007CN1931176A Aescin medicine composition and its prepn process and use
03/21/2007CN1931174A Aspirin buccal tablet and its prepn process
03/21/2007CN1931172A Medicine composition for treating pulpitis
03/21/2007CN1931159A Superfine Iguratimod powder and quick released oral prepn
03/21/2007CN1931146A Tripterygium glycosides soft capsule and its prepn process
03/21/2007CN1931134A Nanometer solid isovitamin A acid lipoid particle and its prepn process
03/21/2007CN1931131A Oil-in-water type nanometer peonol emulsion oral liquid and its prepn process
03/21/2007CN1305906C Use of antibodies against specific MHC-Peptide complexes
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305839C Phenylglycine derivatives
03/21/2007CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries
03/21/2007CN1305507C Medicinal spirit for rheumatism
03/21/2007CN1305489C Rheumatism treating plaster with 'Miao' ethnic drug Heiguteng and preparation process thereof
03/21/2007CN1305475C Boronic ester and acid compounds, synthesis and uses
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192945 Benzothiazepine derivatives
03/20/2007US7192940 Ether compounds
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192928 T cell antigen receptor peptides
03/20/2007US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain
03/20/2007US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
03/20/2007US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
03/20/2007US7192616 Slow down or even inhibit cellular differentiation and/or proliferation.
03/20/2007US7192611 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer
03/20/2007US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins
03/20/2007US7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
03/20/2007CA2360655C Pharmaceutical compositions
03/20/2007CA2162154C Use of a transition metal complex for the treatment of septic shock
03/15/2007WO2007030080A1 Heterocyclic compounds
03/15/2007WO2007029107A1 Isoquinolines derivatives as igf-1r inhibitors
03/15/2007WO2007028256A2 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
03/15/2007WO2007028211A1 Composition of whey growth factor extract for reducing muscle inflammation
03/15/2007WO2006133941A3 Cannabinoid active pharmaceutical ingredient for improved dosage forms
03/15/2007WO2006122769A3 Substituted spiro compounds and their use for producing pain-relief drugs
03/15/2007WO2006106437A8 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
03/15/2007WO2006087644A3 Macrolides with anti-inflammatory activity
03/15/2007US20070060647 Gene expression regulating agent
03/15/2007US20070060619 Nicotinamide-based kinase inhibitors
03/15/2007US20070060595 Novel fused heterocyclic compound and use thereof
03/15/2007US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto
03/15/2007US20070060551 Methods of using isothiazole derivatives to treat cancer or inflammation
03/15/2007US20070060544 4-Nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivatives and their pharmaceutical use
03/15/2007US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis